Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay U Sheth

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Drugs & Aging|March 17, 2026
Anti-Vascular Endothelial Growth Factor Biosimilars for Use in the Aging EyeAshish Sharma, Jay U Sheth, Baruch D Kuppermann
Frontiers in Ophthalmology|February 24, 2025
Infectious scleritis: a review of etiologies, clinical features, and management strategiesSupriya Sharma, Jay U Sheth, Somasheila I Murthy
Clinical Ophthalmology (Auckland, N.Z.)|July 21, 2021
Intraretinal Cysts in Macular Hole: A Structure-Function Correlation Based on En Face ImagingUnnikrishnan Nair, Jay U Sheth, Asmita Indurkar, et al.
Ophthalmology and Therapy|April 12, 2022
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World EvidenceManoj Soman, Indu Nair, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 16, 2026
Vitrectomy with Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage: A Multicenter Retrospective Analysis of Functional and Anatomical Outcomes Across Multiple EtiologiesSomnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 3, 2025
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort StudySomnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
American Journal of Ophthalmology Case Reports|February 24, 2022
Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case seriesDebdulal Chakraborty, Jay U Sheth, Soumen Mondal, et al.
Retina (Philadelphia, Pa.)|February 23, 2017
CHARACTERIZATION OF MACULAR CHOROIDAL THICKNESS IN ISCHEMIC AND NONISCHEMIC DIABETIC MACULOPATHYJay U Sheth, Anantharaman Giridhar, Bindu Rajesh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2025
Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study)Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 16, 2026
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Treatment-Naïve Diabetic Macular Edema (BIOS-DME Study)Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Drugs & Aging|March 17, 2026
Anti-Vascular Endothelial Growth Factor Biosimilars for Use in the Aging EyeAshish Sharma, Jay U Sheth, Baruch D Kuppermann
Frontiers in Ophthalmology|February 24, 2025
Infectious scleritis: a review of etiologies, clinical features, and management strategiesSupriya Sharma, Jay U Sheth, Somasheila I Murthy
Clinical Ophthalmology (Auckland, N.Z.)|July 21, 2021
Intraretinal Cysts in Macular Hole: A Structure-Function Correlation Based on En Face ImagingUnnikrishnan Nair, Jay U Sheth, Asmita Indurkar, et al.
Ophthalmology and Therapy|April 12, 2022
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World EvidenceManoj Soman, Indu Nair, Jay U Sheth, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 16, 2026
Vitrectomy with Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage: A Multicenter Retrospective Analysis of Functional and Anatomical Outcomes Across Multiple EtiologiesSomnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 3, 2025
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort StudySomnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
American Journal of Ophthalmology Case Reports|February 24, 2022
Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case seriesDebdulal Chakraborty, Jay U Sheth, Soumen Mondal, et al.
Retina (Philadelphia, Pa.)|February 23, 2017
CHARACTERIZATION OF MACULAR CHOROIDAL THICKNESS IN ISCHEMIC AND NONISCHEMIC DIABETIC MACULOPATHYJay U Sheth, Anantharaman Giridhar, Bindu Rajesh, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 30, 2025
Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study)Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 16, 2026
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Treatment-Naïve Diabetic Macular Edema (BIOS-DME Study)Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, et al.
Pageof 3